Seuraa
John GF Cleland
John GF Cleland
University of Glasgow & Imperial College London
Vahvistettu sähköpostiosoite verkkotunnuksessa glasgow.ac.uk - Kotisivu
Nimike
Viittaukset
Viittaukset
Vuosi
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
P Ponikowski, AA Voors, SD Anker, H Bueno, JGF Cleland, AJS Coats, ...
Polish Heart Journal (Kardiologia Polska) 74 (10), 1037-1147, 2016
257222016
2018 ESC/ESH Guidelines for the management of arterial hypertension
B Williams, JGF Cleland
European Heart Journal 39, 3021-3104, 2018
155962018
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failureDeveloped by the Task Force for the diagnosis and treatment of acute and chronic heart …
TA McDonagh, M Metra, M Adamo, RS Gardner, A Baumbach, M Böhm, ...
European Heart Journal, 2021
130842021
Cardiac Resynchronization-Heart Failure Study I. The effect of cardiac resynchronization on morbidity and mortality in heart failure
JG Cleland, JC Daubert, E Erdmann, N Freemantle, D Gras, ...
N Engl J Med 352 (15), 1539-1549, 2005
70702005
2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of …
Authors/Task Force Members, M Brignole, A Auricchio, G Baron-Esquivias, ...
European heart journal 34 (29), 2281-2329, 2013
38552013
Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005) The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of …
K Swedberg, J Cleland, H Dargie, H Drexler, F Follath, M Komajda, ...
European heart journal 26 (11), 1115-1140, 2005
28652005
Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised …
PA Poole-Wilson, K Swedberg, JGF Cleland, A Di Lenarda, P Hanrath, ...
The Lancet 362 (9377), 7-13, 2003
27582003
Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure
R Garg, S Yusuf, WD Bussmann, P Sleight, A Uprichard, B Massie, ...
Jama 273 (18), 1450-1456, 1995
23961995
Angiotensin–neprilysin inhibition in heart failure with preserved ejection fraction
SD Solomon, JJV McMurray, IS Anand, J Ge, CSP Lam, AP Maggioni, ...
New England Journal of Medicine 381 (17), 1609-1620, 2019
22972019
The EuroHeart Failure survey programme—a survey on the quality of care among patients with heart failure in Europe: Part 1: patient characteristics and diagnosis
JGF Cleland, K Swedberg, F Follath, M Komajda, A Cohen-Solal, ...
European heart journal 24 (5), 442-463, 2003
22252003
β Blockade after myocardial infarction: systematic review and meta regression analysis
N Freemantle, J Cleland, P Young, J Mason, J Harrison
Bmj 318 (7200), 1730-1737, 1999
21751999
Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure
C JG
N Engl J Med 352, 1539-1549, 2005
21592005
Rosuvastatin in older patients with systolic heart failure
J Kjekshus, E Apetrei, V Barrios, M Böhm, JGF Cleland, JH Cornel, ...
New England Journal of Medicine 357 (22), 2248-2261, 2007
21082007
The perindopril in elderly people with chronic heart failure (PEP-CHF) study
JGF Cleland, M Tendera, J Adamus, N Freemantle, L Polonski, J Taylor
European heart journal 27 (19), 2338-2345, 2006
20552006
Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure
M Packer, PA Poole-Wilson, PW Armstrong, JGF Cleland, JD Horowitz, ...
Circulation 100 (23), 2312-2318, 1999
18621999
Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial
F Follath, JGF Cleland, H Just, JGY Papp, H Scholz, K Peuhkurinen, ...
The Lancet 360 (9328), 196-202, 2002
16862002
Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals
N Conrad, A Judge, J Tran, H Mohseni, D Hedgecott, AP Crespillo, ...
The Lancet 391 (10120), 572-580, 2018
14002018
Guidelines for cardiac pacing and cardiac resynchronization therapy: the task force for cardiac pacing and cardiac resynchronization therapy of the European Society of …
PE Vardas, A Auricchio, JJ Blanc, JC Daubert, H Drexler, H Ector, ...
European heart journal 28 (18), 2256-2295, 2007
13772007
Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance. Are they …
NG Bellenger, MI Burgess, SG Ray, A Lahiri, AJS Coats, JGF Cleland, ...
European heart journal 21 (16), 1387-1396, 2000
12952000
2023 focused update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment …
TA McDonagh, M Metra, M Adamo, RS Gardner, A Baumbach, M Böhm, ...
European heart journal 44 (37), 3627-3639, 2023
12802023
Järjestelmä ei voi suorittaa toimenpidettä nyt. Yritä myöhemmin uudelleen.
Artikkelit 1–20